84 related articles for article (PubMed ID: 3361190)
1. [Establishment of a cisplatin-resistant human ovarian cancer cell line and the mechanism of resistance].
Kikuchi Y; Iwano I; Miyauchi M; Kita T; Kizawa I; Oomori K; Kato K
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):379-83. PubMed ID: 3361190
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a cisplatin-resistant human ovarian cancer cell line.
Kikuchi Y; Miyauchi M; Kizawa I; Oomori K; Kato K
J Natl Cancer Inst; 1986 Dec; 77(6):1181-5. PubMed ID: 3467111
[TBL] [Abstract][Full Text] [Related]
3. Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cells.
Kikuchi Y; Iwano I; Miyauchi M; Sasa H; Nagata I; Kuki E
Gynecol Oncol; 1990 Nov; 39(2):199-203. PubMed ID: 2227596
[TBL] [Abstract][Full Text] [Related]
4. [Reduced cisplatin-uptake by cisplatin-resistant human ovarian cancer cells].
Kikuchi Y; Iwano I; Miyauchi M
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2895-8. PubMed ID: 3178239
[TBL] [Abstract][Full Text] [Related]
5. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of acquired resistance to cisplatin by a human ovarian cancer cell line.
Kikuchi Y; Iwano I; Miyauchi M; Kita T; Oomori K; Kizawa I; Sugita M; Tenjin Y
Jpn J Cancer Res; 1988 May; 79(5):632-5. PubMed ID: 3136116
[TBL] [Abstract][Full Text] [Related]
7. Possible mechanisms of resistance to cis-diamminedichloroplatinum (II) of human ovarian cancer cells.
Kikuchi Y; Iwano I; Miyauchi M; Kita T; Sugita M; Tenjin Y; Nagata I
Jpn J Cancer Res; 1990; 81(6-7):701-6. PubMed ID: 2119370
[TBL] [Abstract][Full Text] [Related]
8. [Drug resistant mechanisms of platinum derivatives in a human cisplatin resistant ovarian cancer cell line].
Nishiya I; Yoshizumi N; Fujiwara J; Kagabu T
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2871-81. PubMed ID: 3178236
[TBL] [Abstract][Full Text] [Related]
9. [Cytokinetic effects of cisplatin on cisplatin-resistant ovarian cancer cell lines].
Sasa H; Kikuchi Y; Hisano A; Ishii K; Nagata I; Kawai T; Aida S; Sugita M; Sugishita T; Tenjin Y
Hum Cell; 1992 Dec; 5(4):384-91. PubMed ID: 1304801
[TBL] [Abstract][Full Text] [Related]
10. [The mechanism of resistance and its circumvention of cisplatin-resistant human ovarian cancer cells].
Kikuchi Y; Iwano I; Miyauchi M; Kita T; Kuki E; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1348-52. PubMed ID: 2584813
[TBL] [Abstract][Full Text] [Related]
11. Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray.
Sakamoto M; Kondo A; Kawasaki K; Goto T; Sakamoto H; Miyake K; Koyamatsu Y; Akiya T; Iwabuchi H; Muroya T; Ochiai K; Tanaka T; Kikuchi Y; Tenjin Y
Hum Cell; 2001 Dec; 14(4):305-15. PubMed ID: 11925933
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic values of prostaglandin D2 in nude mice bearing human ovarian carcinoma].
Kikuchi Y; Miyauchi M; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):121-8. PubMed ID: 2313142
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation.
Kikuchi Y; Kizawa I; Oomori K; Miyauchi M; Kita T; Sugita M; Tenjin Y; Kato K
Cancer Res; 1987 Jan; 47(2):592-6. PubMed ID: 3791243
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.
Kelland LR; Mistry P; Abel G; Freidlos F; Loh SY; Roberts JJ; Harrap KR
Cancer Res; 1992 Apr; 52(7):1710-6. PubMed ID: 1312897
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of a cisplatin-resistant human ovarian cancer cell line].
Sasa H; Hisano A; Ishii K; Hirata J; Kikuchi Y; Nagata I; Senoo A; Aida S; Tamai S; Sugita M
Hum Cell; 1993 Jun; 6(2):106-13. PubMed ID: 8217948
[TBL] [Abstract][Full Text] [Related]
16. [In vitro and in vivo effects of ginsenoside Rh2 on the proliferation of serous cystadenocarcinoma of the human ovary].
Tode T; Kikuchi Y; Sasa H; Hirata J; Kita T; Imaizumi E; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):589-94. PubMed ID: 1619319
[TBL] [Abstract][Full Text] [Related]
17. Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro.
Kikuchi Y; Iwano I; Kato K
Biochem Biophys Res Commun; 1984 Aug; 123(1):385-92. PubMed ID: 6541042
[TBL] [Abstract][Full Text] [Related]
18. [Cancer chemo-endocrine therapy and its cell biological basis].
Nishiya I
Hum Cell; 1998 Sep; 11(3):109-14. PubMed ID: 10086273
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF
Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322
[TBL] [Abstract][Full Text] [Related]
20. [Isolation of cisplatin-resistant subline from human ovarian cancer cell line and analysis of its cell-biological characteristics].
Yoshiya N; Adachi S; Misawa Y; Yuzawa H; Honda T; Kanazawa K; Takeuchi S Tanaka K; Tanaka K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):7-14. PubMed ID: 2647872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]